As a principal investor, Luminark Holdings deploys its own capital into companies pursuing IPOs, reverse mergers, SPAC transactions, and cross-border public listings. We invest in and structure the path to U.S. public capital markets.
We invest in growth-stage and pre-public companies seeking a path to U.S. capital markets. Our portfolio companies include private enterprises preparing for initial public offerings, established businesses pursuing reverse merger opportunities, international companies pursuing cross-border listings, and SPAC vehicles we back through de-SPAC transactions. Typical investments involve companies with $50M+ in revenue where we deploy capital and structuring as a principal.
Taking a company public is one of the most consequential financial decisions a business will make. We invest our own capital in companies and structure their path to an exchange listing on NYSE or Nasdaq, taking on the risk alongside them as a principal.
For companies seeking a faster, more cost-efficient path to public listing, reverse mergers offer a compelling alternative to traditional IPOs. Luminark Holdings invests in and structures reverse merger transactions as a principal, putting its own capital to work alongside the relevant licensed professionals.
Luminark Holdings invests in and structures SPAC vehicles across the entire lifecycle , from blank check formation through de-SPAC merger and post-closing transition, putting its own capital at risk alongside public shareholders.
The difference between a successful public listing and a troubled one often comes down to capital structure. As a principal investor, Luminark Holdings structures the equity and debt architecture of the companies it backs, aligns shareholder interests, and builds governance frameworks that meet NYSE and Nasdaq standards.
For international companies, accessing U.S. capital markets introduces unique complexity , from foreign private issuer qualifications to dual-listing considerations and multi-jurisdictional regulatory compliance. Luminark Holdings invests in and structures non-U.S. companies through these requirements as a principal.
A sponsor entity forms a blank check company and files an S-1 with the SEC. The SPAC raises capital through an IPO, typically offering units at $10.00. IPO proceeds are deposited into a U.S. trust account protecting investor capital until a business combination process completes.
The management team identifies and evaluates potential acquisition targets across financial, legal, operational, and regulatory dimensions. The SPAC typically has 18–24 months to identify and close a transaction before trust funds are returned to shareholders.
Once a target is identified, the SPAC announces a definitive merger agreement. The de-SPAC process involves SEC filings, shareholder vote, and potential PIPE financing. Public shareholders retain full redemption rights at trust value. Upon closing, the target becomes publicly traded.
After closing, the combined entity operates as a public company on NYSE or Nasdaq. As a backer, Luminark Holdings stays invested through the post-merger transition — SEC reporting, investor relations strategy, corporate governance implementation, and ongoing capital markets support.
A SPAC (Special Purpose Acquisition Company) is a publicly listed blank-check vehicle raised to acquire a private company and bring it to public markets without a traditional IPO. Luminark Holdings invests in and structures SPAC vehicles throughout the full lifecycle — from initial structuring and unit design through SEC registration, NYSE or Nasdaq listing, and target identification. Our team has direct experience structuring rights-based SPAC units, two-tranche private placements, and 15-month deal timelines with extension mechanisms that align sponsor and public investor incentives.
A cross-border IPO involves a non-U.S. company registering securities with the SEC and listing on a U.S. exchange such as the NYSE or Nasdaq. The process typically spans 12 to 18 months and involves SEC registration (S-1 or F-1 filing), selection and engagement of U.S. underwriters, conversion to U.S. GAAP or IFRS-compliant financials, corporate governance restructuring to meet exchange listing standards, roadshow preparation. Luminark Holdings invests in and structures the full process — from initial readiness assessment through listing day — with particular expertise in companies based in the Asia-Pacific region pursuing U.S. capital access.
The NYSE and Nasdaq differ in listing standards, investor base composition, and brand perception. NYSE typically attracts more institutional and international investors and carries a stronger brand for large-cap and mid-cap companies, particularly in financial services and industrials. Nasdaq is generally preferred by technology and growth-oriented companies and offers slightly more flexible initial listing standards. For cross-border companies and SPAC vehicles, exchange selection depends on the target market cap, sector, investor targeting strategy, and underwriter relationships. Luminark Holdings evaluates both exchanges as part of structuring its investments and has backed listings on both.
A reverse merger involves a private company acquiring a publicly traded shell company to gain public company status without a traditional IPO. It is typically faster and less expensive than an IPO, making it appropriate for companies that need accelerated access to public markets, have strong fundamentals but lack the IPO readiness for a full SEC registration process, or are seeking a cost-effective path to U.S. listing. The tradeoff is lower immediate capital raise and reduced institutional visibility compared to a full IPO. Luminark Holdings invests in and structures reverse mergers as part of a broader capital deployment strategy, often combining the initial merger with a subsequent registered offering to raise additional capital once public company status is established.
Timeline varies significantly by transaction type. A traditional IPO typically takes 12 to 18 months from initial preparation through listing, including 6 to 9 months of SEC review and comment process. A SPAC IPO can be executed in 3 to 6 months once the sponsor structure is in place. A SPAC de-merger — the acquisition of a private target by a listed SPAC — typically takes 4 to 8 months from announcement to closing. A reverse merger can close in 2 to 4 months. All timelines depend on the company's readiness, the quality of financial statements, SEC comment cycles, and market conditions at the time of execution.
Ready to Begin
Every public listing we back starts with a conversation. Let's discuss how Luminark Holdings can invest in your company's path to U.S. capital markets.
Connect ↗